MedTrace Logo

Lung Nodule Intervention Cohort Study

NCT05441202 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2022-07-01

No results posted yet for this study

Summary

Incident lung nodule is quite common in China. The major treatment method is long-term floolow up without a specific intervention. We aim to investigate the efficacy an safty of a novel transdermal therapy with Chinese herb. The study included two arms: one arm is routine treatment and another arm is routine treatment plus transdermal therapy. The study end point is the change of lung nodule size under CT scan.

Conditions

  • Incident Lung Nodule

Interventions

DEVICE

transdermal therapy

transdermal therapy with Chinese medicine

Sponsors & Collaborators

  • Chinese Chronic Respiratory Disease Research Network

    lead NETWORK

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-07-31
Completion
2025-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05441202 on ClinicalTrials.gov